WindRose Health Investors Makes Strategic Investment in BPD
August 3, 2022
WindRose Health Investors, a New York-based healthcare private equity firm, has completed a strategic recapitalization investment in BPD, a Boca Raton-based provider of data-driven marketing services for hospitals and health systems. The founders and management team will continue to lead and remain significant shareholders as WindRose supports BPD's expansion of service offerings and accelerated growth.
- Buyers
- WindRose Health Investors
- Targets
- BPD, LLC
- Sellers
- BPD founders and management team
- Industry
- Marketing & Advertising
- Location
- Florida, United States
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
WindRose Health Investors Recapitalizes Traditions Behavioral Health
November 14, 2018
Healthcare Services
Funds managed by WindRose Health Investors completed a recapitalization of Traditions Behavioral Health (TBH), a West Coast provider of permanent outsourced physician psychiatric services. WindRose partnered with TBH's executive team (founder and CEO Gary A. Hayes remains in place) to provide growth capital to expand into new U.S. markets, broaden services and increase its network of psychiatrists.
-
MJH Life Sciences Acquires BPD Healthcare
October 22, 2025
Marketing & Advertising
MJH Life Sciences has acquired BPD Healthcare, a tech-enabled marketing and communications partner for health systems and healthcare innovators. The acquisition, completed Oct. 22, 2025 with terms undisclosed, expands MJH's capabilities in data-driven marketing, communications and strategic advisory services; WindRose Health Investors sold its stake in BPD.
-
WindRose Health Investors Recapitalizes Bluestone Physician Services
April 14, 2021
Healthcare Services
WindRose Health Investors completed an equity recapitalization of Bluestone Physician Services to provide growth capital and support expansion. Bluestone — a provider of on-site primary care, care coordination, and behavioral health services for high-risk, geriatric and disabled patients — will continue to be led by founder Dr. Todd Stivland, who and the executive team retain a significant minority stake.
-
WindRose Health Investors Recapitalizes RevHealth
July 27, 2022
Healthcare Services
WindRose Health Investors completed a recapitalization of RevHealth, a Morristown, New Jersey-based omnichannel healthcare communications agency. The investment will provide capital to support RevHealth's growth and expansion of services; founders Bruce Epstein, Bruce Medd, and Brian Wheeler will continue to lead the company and remain significant shareholders.
-
WindRose Health Investors Recapitalizes Lykan Bioscience Holdings
June 4, 2019
Biotechnology
WindRose Health Investors completed an equity recapitalization of Lykan Bioscience Holdings, LLC, a Hopkinton, Massachusetts-based contract manufacturing services organization focused on cell and gene therapy production and logistics. The investment provides capital to support growth and the build-out of a 60,000+ square foot cGMP facility to expand manufacturing capacity; terms were not disclosed.
-
WindRose Health Investors Invests in Stellus Rx
December 8, 2025
Healthcare Services
WindRose Health Investors has made a strategic growth investment in Stellus Rx, a Plano, Texas–based technology-enabled, value-based pharmacy care management platform. The undisclosed transaction will fund Stellus Rx’s expansion of clinical and operational capabilities and the scaling of its platform to serve additional patient populations nationwide.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.